Racial and ethnic disparities in biologic prescriptions for asthma in the United States

Health disparities in allergic diseases

“…Contrary to prior studies that have indicated under-prescription of controller medications and less access to biologics for Black patients, a retrospective cohort study of a claims-based database found comparable rates of anti-IL5 agents and higher rates of omalizumab use amongst black patients compared to White patients, but lower rates of anti-IL-5 agents in Hispanic patients [19]. One survey study with over 3000 respondents found that Black children were more likely to have reported receiving an asthma action plan and more likely to have taken a course on asthma management than non-Hispanic white children [20].…”

Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria

“…It is promising that omalizumab is available in a wide variety of countries, but the fact that some are excluded demonstrates that there are still limitations to access of healthcare in some countries which has been reported for biologics and treatment of asthma in the United States. 13 Surprisingly, 119 reported that patients paid for their own therapy; depending on the healthcare system, this may represent a significant cost and large barrier to access to omalizumab in some patients who do not have these resources. Many survey respondents were unable to estimate the cost to patients when prescribing omalizumab.…”

Persistent sex and race disparities in United States anaphylaxis mortality from 1999 to 2020

“…Novel biologics entered US markets in 2003 and may be the cause of the increasing white trend as there are proportionally more White patients receiving biologics compared to other race groups. 7 The limitations of this study relates to its observational nature; therefore, no statement of causality can be made. Race analyses were limited to White and Black populations and lacked Hispanic ethnicity due to small numbers.…”

“…gov/ contr oller/ datar equest/ D176. Ingrid Salciccioli 1,2 Padmanabh Bhatt 1,2 Joseph Shalhoub 3,4 Dominic Marshall 4,5,6 Justin Salciccioli 2,7 Kimberly Blumenthal Black EAPC was +0.9 but nonsignificant (95% CI −0.5, 2.3; p = .2). White EAPC demonstrated a biphasic pattern, from 1999 to 2004, the EAPC was −5.8 (95% CI −10.4, −1.0; p = .02), while from 2004 to 2020, the EAPC was +2.1 (95% CI 1.3, 3.0; p < .001).…”